ARTICLE | Emerging Company Profile
Verastem: Cancer stem cell engine
Verastem removes bottleneck to finding drug compounds against cancer stem cells
August 15, 2011 7:00 AM UTC
Cancer stem cells have long been recognized as important therapeutic targets, but growing enough of them to allow for screening with typical drug discovery methods has been a challenge. Verastem Inc. believes its techniques have removed the bottleneck to high throughput screening.
Cancer stem cells (CSCs), which often remain after treatment with chemo- or radiotherapies, are believed to be responsible for disease recurrence and can migrate through the body to form metastases...